<DOC>
	<DOCNO>NCT01612390</DOCNO>
	<brief_summary>Sublingual misoprostol superior oxytocin reduction blood loss third fourth stage labor</brief_summary>
	<brief_title>Comparison Sublingual Misoprostol Intravenous Oxytocin Active Management Third Stage Labor</brief_title>
	<detailed_description>Sublingual misoprostol superior oxytocin reduction blood loss third fourth stage labor The data pharmacokinetics study suggest bioavaiblitiy misoprostol sub-lingual administration high oral vaginal administration</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Women aheathy singleton pregnancy spontaneous induced labor term . Hypersensitivity/Contraindication prostaglandins Antepartum hemorrhage Multiple pregnancy Cardiac disease Malpresentation Rhesus negative mother hypersensitive disorder Severe anaemia ( hemoglobin &lt; 7g/dl )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>postpartum hemorrhage</keyword>
</DOC>